Phase I Oncology
Why Salus
Salus IRB board members are highly experienced in reviewing oncology research, including Phase I. Board members are familiar with oncology research design and protocol development, and board membership includes a radiation safety officer, oncology nurse, and a patient advocate in oncology.
Salus offers:
- An experienced, CIP-certified Client Services Manager (CSM) assigned to each project from study start-up to close-out
- Competitive review and response times
- Rapid study start-up
- Streamlined submission process
- Immediate notification of board decisions following meetings
- Development of site-specific submission forms
- Development of site-specific template informed consent documents
- Same-day approval for minor modifications to approved research
- GlobeSync™ Virtual Workspace allowing 24/7 secure access to the complete IRB study file
For more information, contact Client Services.